Ubs Asset Management Americas Inc Procept Bio Robotics Corp Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 52,076 shares of PRCT stock, worth $3.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,076
Previous 44,223
17.76%
Holding current value
$3.29 Million
Previous $1.85 Million
38.86%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PRCT
# of Institutions
173Shares Held
38.1MCall Options Held
386KPut Options Held
259K-
Cpmg Inc Dallas, TX5.33MShares$337 Million100.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.25MShares$268 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$208 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.94MShares$186 Million0.09% of portfolio
-
Alliancebernstein L.P. New York, NY1.99MShares$125 Million0.04% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.82B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...